top of page

Who We Are

Pioneering Cancer Treatment with
Dye Drug Conjugates.

Lahjavida has developed a novel drug delivery platform called a Dye Drug Conjugate (DDC). This technology enhances cancer treatments by precisely targeting tumors while protecting healthy tissues. Dye Drug Conjugates remain non-toxic during circulation and activate only when they reach cancer cells, ensuring focused treatment.

Discover Lahjavida.

AdobeStock_705051370.jpeg
pexels-ivan-samkov-6436252.jpg

Innovation and Expertise in Dye and Molecular Design.

With 25 years of expertise in tumor-targeting dye technology, Lahjavida is pioneering a new approach.

 

Our Dye Drug Conjugate platform uses a tumor-targeting dye to deliver chemotherapy directly to cancer cells, minimizing harm to healthy tissues. This groundbreaking approach combines proven tumor-targeting dye technology with chemotherapy drug efficacy. 

Ocean

Our Technology
Learn more about the results of our Dye Drug Conjugates

Lahjavida, Inc. manages the cancer project and develops the conjugates for testing.

© 2024 by ​Lahjavida, Inc.

​

The treatments discussed on this website have not yet been approved by the United States Food & Drug Administration.

​

Contact Us:

1096 Elkton Dr., Suite 600 
Colorado Springs, CO 80907 

info@Lahjavida.com


Phone: (719) 592-1557

bottom of page